Skip to main content

Table 1 Anthropometric and clinical characteristics of IgAN patients categorized by quartile of TyG–BMI

From: Association of triglyceride glucose–body mass index and left ventricular hypertrophy in patients with IgA nephropathy: a retrospective study

Characteristics

Total

(n = 327)

Quartiles of TyG–BMI

p value

Quartile 1 (n = 82)

 < 173.2

Quartile 2 (n = 82)

173.2 to  < 201.6

Quartile 3 (n = 82)

201.6 to  < 228.5

Quartile 4 (n = 81)

 > 228.5

Age (years)

39.37 ± 10.92

32.91 ± 9.09

41.00 ± 11.25

42.68 ± 10.60

40.91 ± 10.06

 < 0.001*

Gender (Males n,%)

173 (52.91)

25 (30.49)

47 (57.32)

47 (57.32)

54 (66.67)

 < 0.001*

Height (m)

1.64 ± 0.08

1.63 ± 0.07

1.64 ± 0.09

1.64 ± 0.08

1.65 ± 0.08

0.424

Weight (kg)

65.38 ± 15.15

51.99 ± 6.31

61.36 ± 7.59

68.19 ± 6.96

80.18 ± 18.91

 < 0.001*

BMI (kg/m2)

24.24 ± 5.02

19.49 ± 1.58

22.83 ± 1.32

25.18 ± 0.98

29.52 ± 6.55

 < 0.001*

Smoking (n, %)

19 (5.81)

2 (2.44)

3 (3.66)

6 (7.31)

8 (9.88)

0.159

Alcohol use (n, %)

9 (2.75)

1 (1.22)

0 (0)

3 (3.66)

5 (6.17)

0.077

SBP (mmHg)

128.44 ± 19.35

118.71 ± 16.18

129.88 ± 22.29

131.24 ± 16.86

134.01 ± 18.18

 < 0.001*

DBP (mmHg)

85.81 ± 13.42

79.99 ± 10.85

87.18 ± 16.86

88.48 ± 11.06

87.61 ± 12.47

 < 0.001*

RAS blocking agents (n,%)

45(13.76)

5 (6.10)

10 (12.20)

17 (20.73)

13 (16.05)

0.048*

Hemoglobin (g/l)

131.78 ± 19.61

126.87 ± 17.57

134.5 ± 19.54

131.26 ± 21.47

134.52 ± 18.98

0.042*

CRP

0.96 (0.07–3.31)

1.57 (0.07–5.36)

0.42 (0.07–2.25)

2.18 (0.18–3.81)

0.32 (0.07–1.95)

0.264

PCR

897.49 (365.11–1882.65)

926.58 (341.02–2092.44)

715.47 (350.01–1631.53)

1017.26 (415.15–1918.61)

936.62 (402.07–1953.22)

0.612

ACR

500.55 (212.30–1113.60)

518.76 (186.08–1155.78)

422.10 (201.77–1020.03)

545.59 (228.09–1116.13)

530.89 (204.05–1178.53)

0.427

Triglyceride (mg/dl)

1.74 ± 1.42

0.95 ± 0.42

1.35 ± 0.68

1.70 ± 0.58

2.98 ± 2.20

 < 0.001*

Total cholesterol (mg/dl)

4.78 ± 1.31

4.82 ± 1.05

4.70 ± 1.27

4.55 ± 1.52

5.06 ± 1.33

0.385

LDL-C (mg/dl)

2.81 ± 1.14

2.79 ± 0.91

2.73 ± 1.13

2.77 ± 1.42

2.93 ± 1.07

0.420

HDL-C (mg/dl)

1.19 ± 0.39

1.24 ± 0.41

1.20 ± 0.51

1.12 ± 0.31

1.20 ± 0.32

0.327

TyG index

8.44 ± 0.62

7.92 ± 0.39

8.27 ± 0.44

8.56 ± 0.37

9.02 ± 0.64

 < 0.001*

Serum creatinine (mg/dl)

90.00 (69.00–125.00)

75.68 (57.15–94.58)

98.75 (74.28–143.00)

92.50 (72.73–133.25)

101.00 (79.00–135.00)

 < 0.001*

Uric acid (mg/dl)

395.78 ± 105.64

347.43 ± 87.29

399.01 ± 110.58

403.04 ± 104.69

434.10 ± 101.67

 < 0.001*

Urea nitrogen (mg/dl)

6.02 ± 3.05

4.92 ± 1.94

6.40 ± 3.19

6.27 ± 3.54

6.50 ± 3.07

0.002*

eGFR (ml/min/1.73 m2)

80.36 ± 32.00

98.02 ± 27.80

74.60 ± 31.19

75.97 ± 31.03

72.77 ± 31.60

 < 0.001*

LVM (g)

142.42 ± 39.64

114.17 ± 27.68

141.82 ± 38.23

146.66 ± 31.70

167.33 ± 40.79

 < 0.001*

LVMI (g/m2.7)

37.34 ± 9.38

30.41 ± 6.75

37.32 ± 8.91

38.26 ± 7.55

43.45 ± 9.32

 < 0.001*

LVH (n, %)

44 (13.46)

2 (2.44)

9 (10.98)

9 (10.98)

24 (29.63)

 < 0.001*

UTP

1101.82 (491.00–2361.12)

1162.44 (478.91–2685.15)

892.80 (454.66–2056.86)

781.23 (385.22–1646.65)

573.00 (243.33–1293.73)

0.624

Urinary sodium (mmol/L)

68.97 ± 32.35

68.16 ± 31.85

67.04 ± 28.53

74.37 ± 38.95

66.26 ± 28.90

0.913

Urinary potassium (mmol/L)

17.71 ± 7.94

17.88 ± 8.46

17.02 ± 7.17

18.09 ± 7.91

17.83 ± 8.25

0.813

Serum sodium(mmol/L)

140.93 ± 2.22

140.38 ± 2.34

141.16 ± 2.37

141.15 ± 1.76

141.02 ± 2.32

0.086

Serum potassium (mmol/L)

3.74 ± 0.39

3.65 ± 0.30

3.77 ± 0.43

3.78 ± 0.37

3.78 ± 0.43

0.034*

  1. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; RAS, renin–angiotensin system; CRP, C-reactive protein; PCR, urinary protein to creatinine ratio; ACR, urinary albumin-to-creatinine ratio; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; eGFR, estimated Glomerular Filtration Rate; LVM, left ventricular mass; LVMI, left ventricular mass index; LVH, left ventricular hypertrophy; UTP, 24 urinary total protein.
  2. p < 0.05 compared with Quartile 1 of TyG–BMI
  3. p < 0.01 compared with Quartile 1 of TyG–BMI
  4. *There is a statistically significant difference